The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

1 Apr 2022 07:00

RNS Number : 8493G
Circassia Group Plc
01 April 2022
 

Circassia Group plc

Block Listing Interim Review

 

Oxford, UK - 1 April 2022: Circassia Group plc (LSE: CIR), a medical device company focused on point of care asthma diagnosis and management, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

Name of the company:

Circassia Group plc

Name of relevant scheme:

1) Circassia EMI Share Option Scheme

2) Circassia 2007 Unapproved Share Scheme

3) Circassia 2014 Performance Share Plan Scheme

4) Circassia 2015 Performance Share Plan Scheme

5) Circassia 2016 Performance Share Plan Scheme

6) Circassia 2017 Performance Share Plan Scheme

7) Circassia 2020 Save As You Earn Scheme (UK)

8) Circassia 2020 Performance Share Plan Scheme

9) Circassia 2020 Deferred Share Bonus Plan

Period of return:

From:

1 October 2021

To:

31 March 2022

Balance of unallotted securities under scheme(s) from previous return:

1) 700,750

2) 203,000

3) 76,676

4) 172,722

5) 580,926

6) 50,672

7) 1,126,893

8) 0

9) 0

Total 2,911,639

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1) - 5) inclusive: Nil

6) 250,000

7) 0

8) 184,091

9) 823,467

Less:  Number of securities issued/allotted under scheme(s) during period:

 

1) - 5) inclusive: Nil

6) (12,050)

7) (61,335)

8) (184,091)

9) (823,467)

Total (1,080,943)

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1) 700,750

2) 203,000

3) 76,676

4) 172,722

5) 580,926

6) 288,622

7) 1,065,558

8) 0

9) 0

Total 3,088,254

Number and class of securities originally listed and the date of admission:

1) 2,600,000 - 20 March 2014

2) 516,000 - 1 June 2017

3) 500,000 - 1 June 2017

4) 400,000 - 21 May 2018

5) 930,000 - 1 July 2019

6) 980,000 - 22 May 2020

6) 250,000 - 11 October 2021

7) 1,141,658 - 1 April 2021

8) 184,091 - 2 December 2021

9) 823,467 - 28 March 2022 

 

Name of contact:

Sarah Duncan

Telephone number of contact:

01865 405 560

 

For further information, please contact:

Singer Capital Markets (Nominated Adviser and Broker)

Aubrey Powell / Jen Boorer

Tel: +44 (0) 20 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRDZGFFVMFGZZM
Date   Source Headline
27th Jan 202011:47 amRNSHolding(s) in Company
21st Jan 20201:46 pmRNSHolding(s) in Company
17th Jan 20203:34 pmRNSHolding(s) in Company
15th Jan 20202:22 pmRNSHolding(s) in Company
13th Jan 20203:13 pmRNSHolding(s) in Company
10th Jan 20205:39 pmRNSHolding(s) in Company
10th Jan 20205:38 pmRNSHolding(s) in Company
10th Jan 20203:18 pmRNSInvestment in Circassia Pharmaceuticals plc
9th Jan 20204:26 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNSCircassia Announces Business Update
3rd Jan 202011:53 amRNSHolding(s) in Company
31st Dec 20197:00 amRNSTotal Voting Rights
19th Dec 20192:03 pmRNSGrant of Options
19th Dec 20197:04 amRNSUpdate on Licensing Agreement with BeyondAir Inc.
17th Dec 201910:50 amRNSHolding(s) in Company
13th Dec 20194:05 pmRNSHolding(s) in Company
6th Dec 201912:25 pmRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSCircassia Announces Board Changes
3rd Dec 20194:33 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSTotal Voting Rights Update
27th Nov 20191:38 pmRNSHolding(s) in Company
26th Nov 20196:03 pmRNSHolding(s) in Company
26th Nov 20194:55 pmRNSHolding(s) in Company
26th Nov 20194:51 pmRNSHolding(s) in Company
25th Nov 20195:38 pmRNSHolding(s) in Company
25th Nov 20195:35 pmRNSHolding(s) in Company
4th Nov 20192:48 pmRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights Update
21st Oct 20197:00 amRNSUS launch of Duaklir at CHEST 2019
17th Oct 20195:34 pmRNSGrant of options
4th Oct 20194:30 pmRNSHolding(s) in Company
1st Oct 201911:25 amRNSDirector/PDMR Shareholding
30th Sep 201911:06 amRNSTotal Voting Rights
30th Sep 201911:02 amRNSBlock listing Interim Review
26th Sep 20197:00 amRNSInterim Results for Six Months Ended 30 June 2019
20th Sep 20193:37 pmRNSHolding(s) in Company
19th Sep 20195:40 pmRNSHolding(s) in Company
18th Sep 20195:26 pmRNSHolding(s) in Company
18th Sep 20195:21 pmRNSHolding(s) in Company
17th Sep 20191:10 pmRNSHolding(s) in Company
17th Sep 201912:01 pmRNSHolding(s) in Company
16th Sep 20194:51 pmRNSHolding(s) in Company
13th Sep 20195:57 pmRNSBlock listing Interim Review
12th Sep 20197:00 amRNSNotice of Results and Appointment of Joint Broker
30th Aug 20197:00 amRNSTotal Voting Rights
23rd Aug 20195:23 pmRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSAppointment of Jonathan Emms as COO
31st Jul 20191:55 pmRNSTotal Voting Rights
22nd Jul 20194:12 pmRNSHolding(s) in Company
9th Jul 20191:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.